← Leaderboards
Jeannie S Huang
Massachusetts General Hospital
$3,065,334
Attributed
$5,007,134
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $604.7K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,007,134 · 15
By mechanism
R01$2,589,067 · 1
RC1$999,891 · 1
K23$649,755 · 1
M01$516,421 · 11
R21$252,000 · 1
Top collaborators
- Kenneth Denton Craig5 shared
- Marian S Bartlett4 shared
- Matthew Scott Goodwin4 shared
- Virginia De Sa1 shared
- Rana El Kaliouby1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Paola Pajevic Divieti$9,923,104
- Karen K Miller$23,499,917
- Roland E Baron$29,888,429
- Madhusmita Misra$12,646,884
- Jungwoo Lee$3,464,788
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingResearch PersonnelChildClinical ResearchPainAbdominal PainTechnologySourceTrainingMedicalPopulations At RiskBaseHiv InfectionsTarget PopulationsFoundationsGrantComputer Retrieval Of Information On Scientific Projects DatabaseHealthcareResourcesBehaviorInstitutionHuman SubjectCommunicationUnited States National Institutes Of Health
Grant awards (29)
Development of a new technology for assessing pediatric pain (NTAP)$511,044
R01 · FY2016 · NR · contact PI
Development of a new technology for assessing pediatric pain (NTAP)$493,156
R01 · FY2015 · NR · contact PI
Development of a new technology for assessing pediatric pain (NTAP)$502,019
R01 · FY2014 · NR · contact PI
Development of a new technology for assessing pediatric pain (NTAP)$478,192
R01 · FY2013 · NR · contact PI
Development of a new technology for assessing pediatric pain (NTAP)$604,656
R01 · FY2012 · NR · contact PI
TAHLC:Texting to promote Adolescent Health Liaisons & Chronic disease Management$499,891
RC1 · FY2010 · MD · contact PI
A PILOT OPEN-LABELED TRIAL OF SAM-E FOR RECURRENT ABDOMINAL PAIN IN CHILDREN$3,107
M01 · FY2010 · RR · contact PI
PACE-CALL: A TAILORED WEIGHT MANAGEMENT PROGRAM FOR CHILDHOOD ALL SURVIVORS$172
M01 · FY2010 · RR · contact PI
TAHLC:Texting to promote Adolescent Health Liaisons & Chronic disease Management$500,000
RC1 · FY2009 · MD · contact PI
A PILOT OPEN-LABELED TRIAL OF SAM-E FOR RECURRENT ABDOMINAL PAIN IN CHILDREN$4,530
M01 · FY2009 · RR · contact PI
TRIAL OF ZOLEDRONATE IN THE TREATMENT OF HIV-ASSOCIATED OSTEOPENIA$93,844
M01 · FY2008 · RR · contact PI
A PILOT OPEN-LABELED TRIAL OF SAM-E FOR RECURRENT ABDOMINAL PAIN IN CHILDREN$2,748
M01 · FY2008 · RR · contact PI
TRIAL OF ZOLEDRONATE IN THE TREATMENT OF HIV-ASSOCIATED OSTEOPENIA$185,639
M01 · FY2007 · RR · contact PI
BONE DENSITY IN HIV-INFECTED WOMEN$1,671
M01 · FY2007 · RR · contact PI
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$129,951
K23 · FY2006 · AI · contact PI
BONE DENSITY IN HIV-INFECTED WOMEN$59,947
M01 · FY2006 · RR · contact PI
ACTG A5163: ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASE BONE DENSITY$22,156
M01 · FY2006 · RR · contact PI
TRIAL OF ZOLEDRONATE IN THE TREATMENT OF HIV-ASSOCIATED OSTEOPENIA$3,910
M01 · FY2006 · RR · contact PI
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$129,951
K23 · FY2005 · AI
Bisphosphonate therapy for HIV-Associated osteopenia$126,000
R21 · FY2005 · AI
BONE DENSITY IN HIV-INFECTED WOMEN$64,140
M01 · FY2005 · RR
ACTG A5163: ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASE BONE DENSITY$9,386
M01 · FY2005 · RR
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$129,951
K23 · FY2004 · AI
Bisphosphonate therapy for HIV-Associated osteopenia$126,000
R21 · FY2004 · AI
BONE DENSITY IN HIV-INFECTED WOMEN$62,665
M01 · FY2004 · RR
CSF LEPTIN IN HIV INFECTION$2,506
M01 · FY2004 · RR
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$129,951
K23 · FY2003 · AI
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$79,220
K23 · FY2002 · AI
Bone Marrow Fat and Osteopenia in HIV Lipodystrophy$50,731
K23 · FY2002 · AI